Colin Hislop
2013 - Anthera Pharmaceuticals
In 2013, Colin Hislop earned a total compensation of $1M as Chief Medical Officer at Anthera Pharmaceuticals, a 89% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $28,665 |
|---|---|
| Option Awards | $601,998 |
| Salary | $350,000 |
| Stock Awards | $37,847 |
| Total | $1,018,510 |
Hislop received $602K in option awards, accounting for 59% of the total pay in 2013.
Hislop also received $28.7K in non-equity incentive plan, $350K in salary and $37.8K in stock awards.
Rankings
In 2013, Colin Hislop's compensation ranked 6,516th out of 12,286 executives tracked by ExecPay. In other words, Hislop earned more than 47.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,516 out of 12,286 | 47th |
Division Manufacturing | 2,290 out of 4,612 | 50th |
Major group Chemicals And Allied Products | 682 out of 1,466 | 54th |
Industry group Drugs | 497 out of 1,160 | 57th |
Industry Pharmaceutical Preparations | 394 out of 890 | 56th |
Source: SEC filing on April 9, 2015.
Hislop's colleagues
We found four more compensation records of executives who worked with Colin Hislop at Anthera Pharmaceuticals in 2013.